PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 24, 2026Stem Cell Research0 citationsOpen Access

Generation of iPSC line NIMHi033-A from an Indian patient with Autism Spectrum Disorder carrying mutation in DYNC1H1 gene

View Full Paper
AMAshitha S. Niranjana MurthyPCPrincy ChoudharyPSPranshu Sachdeva

Key Points

  • The aim is to generate a human iPSC line to study the impact of a mutation in the DYNC1H1 gene related to autism.
  • Generated iPSC line from peripheral blood mononuclear cells of a 14-year-old male patient.
  • Identified a de novo heterozygous variant in the DYNC1H1 gene.
  • Utilized established protocols for iPSC generation and characterization.
  • Created the iPSC line NIMHi033-A from the patient, allowing for further studies.
  • Identified a likely-pathogenic mutation affecting motor protein function.
  • Predicted impacts on neurotrophic signaling and synaptic functions due to the mutation.

Abstract

We report the generation of a human induced pluripotent stem cell (hiPSC) line from peripheral blood mononuclear cells of a 14-year-old male with Autism Spectrum Disorder carrying a de novo heterozygous likely-pathogenic variation c.4067C>T (p.Pro1356Leu) in Dynein Cytoplasmic 1 Heavy Chain 1 ( DYNC1H1 ) gene. Variation in this gene that encodes a motor protein may affect retrograde transport of neurotrophic signals, synaptic vesicles, organelles like golgi complex and mitochondria. Therefore, this iPSC line will be an invaluable tool to study the effects of this high-risk autism-related variant on disease manifestation and cellular functions.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Murthy et al. (2026) studied this question.

synapsesocial.com/papers/69eb084f553a5433e34b36d0https://doi.org/10.1016/j.scr.2026.103999
Ask AI
Helpful
Bookmark
Share
View Full Paper